Synthpop

Overview
News
Hospital Management?
Product stageSegments
Minimum Viable Product
?
Revenue cycle management
?

Synthpop is a healthcare technology company that provides AI-driven solutions to streamline administrative workflows in the healthcare industry. Its flagship offering is a connected system of multimodal AI agents capable of performing complex tasks such as data entry into electronic medical records (EMRs), connecting patient charts to clinical guidelines and payor policies in real-time, responding to denials and record requests, and providing feedback and summarization during patient visits.

Synthpop's AI agents leverage large language models (LLMs) that have been fine-tuned on existing medical data, ensuring HIPAA compliance and high accuracy out-of-the-box. The company has developed a unique method to de-identify medical records, enabling the safe fine-tuning of AI models without compromising patient privacy and security.

Synthpop's solutions are currently utilized by various healthcare providers, including durable medical equipment (DME) suppliers, sleep medicine clinicians, wound care facilities, and genetic testing providers. The company offers four key products: Fax Wrangler, Field Extractor, Order Validation, and AI Caller (currently in beta), designed to streamline workflows for healthcare providers, suppliers, and software services.

In June 2024, Synthpop secured USD 5.6 million in seed funding led by Peterson Ventures, with participation from defy.vc, Zelda Ventures, Think+ Ventures, and OVO Fund. This funding will enable the company to expand its engineering team, enhance product development, and support its expansion into various healthcare industries.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
67 West St 4 Floor Brooklyn NY USA
Founded year:
2023
Employees:
11-50
IPO status:
Private
Total funding:
USD 8.2 mn
Last Funding:
USD 5.6 mn (Seed; Jun 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.